OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Icahn School of Medicine at Mount Sinai

8 Projects | 7 Researchers | $1,963,989 Invested

2018

Icahn School of Medicine at Mount Sinai

Riccardo Miotto

Deep Learning to Unveil Neurological Disorder Patterns and Novel Therapeutics from the Electronic Health Records

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: Other
  • Status: Closed

2017

Icahn School of Medicine at Mount Sinai

Ana Pereira, MD

Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment - Expansion to an additional clinical site

  • Funding Amount: $106,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed

2016

Icahn School of Medicine at Mount Sinai

Thomas Franke, MD, PhD

Targeting Ca2+ dysregulation in Alzheimer's Disease

  • Funding Amount: $233,505
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Calcium Regulation
  • Status: Closed

2016

Icahn School of Medicine at Mount Sinai

Sam Gandy, MD, PhD

Imaging [18F] AV-1451 and [18F] AV-45 in acute and chronic traumatic brain injury - Add On Funding

  • Funding Amount: $187,069
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2015

Icahn School of Medicine at Mount Sinai

Stephen Salton, MD, PhD

VGF peptide delivery for the suppression of memory impairment in an Alzheimer's disease model

  • Funding Amount: $158,171
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Growth Factors/Neurotrophic Factors
  • Status: Closed

2014

Icahn School of Medicine at Mount Sinai

Sam Gandy, MD, PhD

Imaging [18F]AV-1451 and [18F]AV-45 in acute and chronic traumatic brain injury

  • Funding Amount: $399,822
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Icahn School of Medicine at Mount Sinai

Mary Sano, PhD

Effect of High-Dose Supplements on Blood Homocyteine in Alzheimer's Disease

  • Funding Amount: $178,801
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Icahn School of Medicine at Mount Sinai

Ming-Ming Zhou, PhD

Structure-based Functional Design of Antagonists for Glutamate Receptors

  • Funding Amount: $600,621
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed